How to use Know How & Services

E.g. a search for a conference offering a partnering service will use selection of "Conference, Fair" in 'Sector' and 'Technology Transfer' in 'Technology'.

Technology transfer offices active in partnering can be found by selection of 'Technology Transfer' in 'Sector'. Short profiles summarize the available information and a link of the respective homepage is provided too.

Registered users can create non-public notifications profiles which will inform them about new Know How & Services entries fitting their needs as specified. In addition these profiles allow them to filter the available information more comfortably.

Name

Elicityl is developing complex sugars for therapeutics and plant health

Organization name

Elicityl

Profile

Based near Grenoble, France, ELICITYL is a biotech company devoted to complex sugar engineering and production. The company mission is to supply oligosaccharides and polysaccharides for biological applications targeting plant health, pharmacy, nutraceutics and cosmetics.

ELICITYL has two commercial offers:

OligoTech®: a bank of tailor-made complex sugars

  • Extracted from biomass
  • Produced by bacterial fermentation
  • Potentially modified thru chemical functionalization

The OligoTech® offer gives business opportunities using the untapped variety of complex sugars in compliance with all regulation appliance.  

Complex sugars for Plant health: ELICITYL commercialises PEL101GV®, a complex sugar extracted from biomass enhancing the natural vine resistance to spring frosts.

ELICITYL has an extensive skill in complex sugar manufacturing and valorisation. In particular, the OligoTech® offer is based on the know-how in extraction, purification and fine characterization of complex sugars and on unique industrial production means owned and controlled by ELICITYL. Elicityl´s supplying capabilities include sampling lines to scaled-up industrial processes enabling the delivery from the g to multi kg scale.

ELICITYL coordinates an industrial consortium program to create a bank of complex sugar with screening on antiviral activity (hepatitis C, influenza and dengue viruses). This R&D project (CARBINFEC) is supported by the world competitive cluster, Lyonbiopôle focused on infectious diseases.

Additional information and contact data are provided online.

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.

 
 

latest entries